473 related articles for article (PubMed ID: 33687462)
1. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
[TBL] [Abstract][Full Text] [Related]
2. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
[TBL] [Abstract][Full Text] [Related]
3. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.
Gerlach LB; Olfson M; Kales HC; Maust DT
J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Central Nervous System-Active Medication Use and Fall-Related Injury in Community-Dwelling Older Adults with Dementia.
Hart LA; Marcum ZA; Gray SL; Walker RL; Crane PK; Larson EB
Pharmacotherapy; 2019 May; 39(5):530-543. PubMed ID: 30861179
[TBL] [Abstract][Full Text] [Related]
5. Medication Costs and Use of Older Americans in Assisted Living Settings: a Nationally Representative Cross-Sectional Study.
Lei L; Samus QM; Thomas KS; Maust DT
J Gen Intern Med; 2023 Feb; 38(2):294-301. PubMed ID: 35132546
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Use of Long-Term Medications Following Incident Dementia Diagnosis.
Anderson TS; Ayanian JZ; Curto VE; Politzer E; Souza J; Zaslavsky AM; Landon BE
JAMA Intern Med; 2023 Oct; 183(10):1098-1108. PubMed ID: 37603340
[TBL] [Abstract][Full Text] [Related]
7. Central Nervous System-Active Prescriptions in Older Veterans: Trends in Prevalence, Prescribers, and High-risk Populations.
Burke RE; Pelcher L; Tjader A; Linsky AM; Thorpe CT; Turner JP; Rose L
J Gen Intern Med; 2023 Dec; 38(16):3509-3516. PubMed ID: 37349639
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study.
Wei YJ; Shrestha N; Chiang C; DeKosky ST
Alzheimers Res Ther; 2024 Feb; 16(1):30. PubMed ID: 38326897
[TBL] [Abstract][Full Text] [Related]
9. Trends in central nervous system-active polypharmacy among people with multiple sclerosis.
Naizer H; Wozny J; Krause TM; Huson E; Freeman L
Mult Scler; 2024 May; ():13524585241251986. PubMed ID: 38751229
[TBL] [Abstract][Full Text] [Related]
10. New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge.
Growdon ME; Gan S; Yaffe K; Lee AK; Anderson TS; Muench U; Boscardin WJ; Steinman MA
J Am Geriatr Soc; 2023 Apr; 71(4):1134-1144. PubMed ID: 36514208
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults.
Musich S; Wang SS; Slindee LB; Ruiz J; Yeh CS
Popul Health Manag; 2020 Aug; 23(4):286-296. PubMed ID: 31765280
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
[TBL] [Abstract][Full Text] [Related]
13. Medication misuse and overuse in community-dwelling persons with dementia.
Deardorff WJ; Jing B; Growdon ME; Yaffe K; Boscardin WJ; Boockvar KS; Steinman MA
J Am Geriatr Soc; 2023 Oct; 71(10):3086-3098. PubMed ID: 37272899
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period.
Fick D; Kolanowski A; Waller J
Aging Ment Health; 2007 Sep; 11(5):588-95. PubMed ID: 17882597
[TBL] [Abstract][Full Text] [Related]
15. An investigation of psychoactive polypharmacy and related gender-differences in older adults with dementia: a retrospective cohort study.
Trenaman SC; Quach J; Bowles SK; Kirkland S; Andrew MK
BMC Geriatr; 2023 Oct; 23(1):683. PubMed ID: 37864154
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapeutic management of dementia across settings of care.
Rattinger GB; Burcu M; Dutcher SK; Chhabra PT; Rosenberg PB; Simoni-Wastila L; Franey CS; Walker LD; Zuckerman IH
J Am Geriatr Soc; 2013 May; 61(5):723-33. PubMed ID: 23590231
[TBL] [Abstract][Full Text] [Related]
17. Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia.
Lau DT; Mercaldo ND; Shega JW; Rademaker A; Weintraub S
Am J Alzheimers Dis Other Demen; 2011 Dec; 26(8):606-15. PubMed ID: 22207646
[TBL] [Abstract][Full Text] [Related]
18. Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia.
Bae-Shaaw YH; Shier V; Sood N; Seabury SA; Joyce G
J Alzheimers Dis; 2023; 93(2):471-481. PubMed ID: 37038818
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA).
Slater N; White S; Frisher M
BMJ Open; 2020 Sep; 10(9):e034346. PubMed ID: 32928845
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of potentially inappropriate prescribing of central nervous system and psychotropic drugs among elderly patients: A national population study in Korea.
Cho H; Choi J; Kim YS; Son SJ; Lee KS; Hwang HJ; Kang HY
Arch Gerontol Geriatr; 2018 Jan; 74():1-8. PubMed ID: 28917110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
